|
?:authorAffiliation
|
-
[\'QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.\', \'Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.\', \'J. David Gladstone Institutes, San Francisco, CA, USA.\', \'Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.\', \'Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.\', \'Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.\', \'Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.\', \'Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France.\', \'Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.\', \'Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA.\', \'European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK.\', \'Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.\', \'The UC Berkeley-UCSF Graduate Program in Bioengineering, University of California San Francisco, San Francisco, CA, USA.\', \'Center for Computational Biology and Bioinformatics, Department of Medicine, University of California San Diego, San Diego, CA, USA.\', \'Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA, USA.\', \'Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.\', \'Biophysics Graduate Program, University of California San Francisco, San Francisco, CA, USA.\', \'Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA.\', \'Zoic Labs, Culver City, CA, USA.\', \'Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.\', \'Department of Urology, University of California San Francisco, San Francisco, CA, USA.\', \'Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA.\', \'Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.\', \'George William Hooper Foundation, Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA.\', \'Medical Scientist Training Program, University of California San Francisco, San Francisco, CA, USA.\', \'Virus and Immunity Unit, Institut Pasteur, Paris, France.\', \'Department of Medicine, University of California San Francisco, San Francisco, CA, USA.\', \'Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.\', \'Department of Psychiatry, University of California San Francisco, San Francisco, CA, USA.\', \'Buck Institute for Research on Aging, Novato, CA, USA.\', \'Direction Scientifique, Institut Pasteur, Paris, France.\', \'Division of Genetics, Department of Medicine, University of California San Diego, San Diego, CA, USA.\', \'Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France. marco.vignuzzi@pasteur.fr.\', \'Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Adolfo.Garcia-Sastre@mssm.edu.\', \'Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Adolfo.Garcia-Sastre@mssm.edu.\', \'Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Adolfo.Garcia-Sastre@mssm.edu.\', \'The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Adolfo.Garcia-Sastre@mssm.edu.\', \'QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA. Kevan.Shokat@ucsf.edu.\', \'Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA. Kevan.Shokat@ucsf.edu.\', \'Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA. Kevan.Shokat@ucsf.edu.\', \'Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA. Kevan.Shokat@ucsf.edu.\', \'QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA. shoichet@cgl.ucsf.edu.\', \'Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA. shoichet@cgl.ucsf.edu.\', \'Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA. shoichet@cgl.ucsf.edu.\', \'QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA. nevan.krogan@ucsf.edu.\', \'Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA. nevan.krogan@ucsf.edu.\', \'J. David Gladstone Institutes, San Francisco, CA, USA. nevan.krogan@ucsf.edu.\', \'Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA. nevan.krogan@ucsf.edu.\', \'Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. nevan.krogan@ucsf.edu.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}